| Net income | 747M |
| Depreciation and amortization | 357M |
| Deferred income taxes | -26M |
| Other | |
| Postretirement benefit plan contributions | -29M |
| Trade receivables | -208M |
| Inventories | 25M |
| Accounts payable | 139M |
| Accrued income taxes | 10M |
| Accrued interest expense | 53M |
| Accrued and prepaid advertising, promotion and trade allowances | |
| Accrued salaries and wages | -45M |
| All other current assets and liabilities | -57M |
| Net cash provided by operating activities | 1.02B |
| Additions to properties | -376M |
| Other | -11M |
| Net cash used in investing activities | -381M |
| Net issuances of notes payable | -749M |
| Issuances of long-term debt | 2.06B |
| Reductions of long-term debt | -1.23B |
| Net issuances of common stock | 356M |
| Common stock repurchases | -426M |
| Cash dividends | -533M |
| Other | 0 |
| Net cash used in financing activities | -521M |
| Effect of exchange rate changes on cash and cash equivalents | -24M |
| Increase in cash and cash equivalents | 95M |
| Cash and cash equivalents at beginning of period | 251M |
| Cash and cash equivalents at end of period | 346M |